ADGM_OUT_1 [2025-04-17 09:48:32 -0400] 3234 Bytes | 814 tokens | Cum: 814 tkns (10.17% of 8k)
==========================================================================

We need a winner today and it's already 9:48:31 AM on Thu Apr 17, 2025 -0400 ... So let's find out if Adagio Medical (ADGM) is going up or if it's going nowhere fast. So, I pulled together a bunch of data for you to look over real fast. It's at 1.3800 up from 0.9232. Is there something here we can get excited about? Help me analyze.

--- COMPANY PROFILE ---
Company: Adagio Medical (ADGM)
IPO: 2024-08-01 (8 Months Ago)
Market Cap: $14,200,261
Shares Outstanding: 15,380,000
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange: XNAS
Description: Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

Here’s a list of headlines for Adagio Medical:

Today 08:30AM - Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System
Mar-31-25 04:01PM - Adagio Medical Appoints Deborah Kaster as Chief Business Officer
Mar-31-25 04:01PM 08:30AM - Adagio Medical Reports Fourth Quarter and Full Year 2024 Results
Mar-17-25 04:01PM - Adagio Medical Provides Clinical and Business Updates
Feb-28-25 08:30AM - Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
Feb-18-25 04:01PM - Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference
Dec-16-24 08:00AM - Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director
Nov-14-24 04:01PM - Adagio Medical Reports Third Quarter 2024 Results

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Adagio Medical (ADGM).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

ADGM_OUT_3 [2025-04-17 09:48:33 -0400] 908 Bytes | 266 tokens | Cum: 1082 tkns (13.53% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T14:07:40Z - Adagio Medical Holdings reports Q4 results (NASDAQ:ADGM)...
A2 - 2025-03-19T12:07:12Z - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Adagio Medical Holdings (NASDAQ:ADG...
A3 - 2025-03-18T21:05:48Z - 12 Health Care Stocks Moving In Tuesday's After-Market Session - Adagio Medical Holdings (NASDAQ:ADG...
A4 - 2025-03-17T20:11:10Z - Adagio Medical (ADGM) Provides Clinical and Business Updates...
A5 - 2025-03-17T20:06:05Z - Adagio Medical Provides Clinical and Business Updates...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ADGM_OUT_5 [2025-04-17 09:48:35 -0400] 940 Bytes | 267 tokens | Cum: 1351 tkns (16.89% of 8k)
==========================================================================

Showing A1 (chunk 1 of 1): A1:
**Adagio Medical Holdings reports Q4 results (NASDAQ:ADGM)**Date: 2025-03-31Source: {'uri': 'seekingalpha.com', 'dataType': 'news', 'title': 'Seeking Alpha'}URL: https://seekingalpha.com/news/4426949-adagio-medical-holdings-reports-q4-resultsAdagio Medical Holdings, Inc. press release (NASDAQ:ADGM): Revenue was $137 thousand for the fourth quarter of 2024, up 76% compared to $78 thousand for the fourth quarter of 2023. Net loss was $57.4 million for the fourth quarter of 2024 compared to a net loss of $8.6 million in the same period of the prior year.

More on Adagio Medical Holdings, Inc.

Financial information for Adagio Medical Holdings, Inc.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_7 [2025-04-17 09:48:37 -0400] 1102 Bytes | 280 tokens | Cum: 1633 tkns (20.41% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-04-02 8-K Item 2.02. Results of Oper and Fin Cond.

On March 31, 2025, Adagio Medical Holdings, Inc. (the Company), issued a press release announcing the Companys financial results for the fiscal year ended December 31, 2024. A copy of this press release is furnished as E...

S2 - 2025-03-27 10-K Item 7. Mgts Discussion and Analysis of Fin Cond and Results of Oper.

The following discussion and analysis of financial condition and results of operations should be read together with the CONS financial statements as of and for the years ended...

S8 - 2025-03-17 8-K Item 7.01. Regulation FD Disclosure.

On March 17, 2025, the Company issued a press release regarding Mr. Dahldorf's departure and certain business updates. A copy of the press release is being furnished as Exhibit 99.1 and is incorporated herein by reference.

The information i...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ADGM_OUT_9 [2025-04-17 09:48:38 -0400] 1104 Bytes | 269 tokens | Cum: 1904 tkns (23.80% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 2.02. Results of Operations and Financial Condition.

On March 31, 2025, Adagio Medical Holdings, Inc. (the Company), issued a press release announcing the Companys financial results for the fiscal year ended December 31, 2024. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act, except as expressly set forth by specific reference in such a filing....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

ADGM_OUT_11 [2025-04-17 09:48:47 -0400] 7255 Bytes | 1977 tokens | Cum: 3883 tkns (48.54% of 8k)
==========================================================================

This is our set of metrics for Adagio Medical.
Please analyze the numbers.

+---------------------+----------------------+------------------------+-------------------+
| Volume: 1,254,068 | Perf Month: 8.00% | Option/Short: No / Yes | Sales Y/Y TTM: - |
+---------------------+----------------------+------------------------+-------------------+
| Avg Volume: 123.97K | Perf Quarter: 18.51% | Short Float: 0.55% | ROE: -329.16% |
+---------------------+----------------------+------------------------+-------------------+
| Rel Volume: 176.51 | Index: - | Short Ratio: 0.67 | ROI: -208.25% |
+---------------------+----------------------+------------------------+-------------------+
| RSI (14): 55.95 | Market Cap: 15.00M | Short Interest: 0.08M | Sales Surprise: - |
+---------------------+----------------------+------------------------+-------------------+
| ATR (14): 0.12 | Shs Outstand: 15.20M | Beta: 0.07 | EPS Surprise: - |
+---------------------+----------------------+------------------------+-------------------+
| SMA20: 16.28% | Shs Float: 15.10M | Sales Q/Q: - | P/E: - |
+---------------------+----------------------+------------------------+-------------------+
| SMA50: -5.13% | Inst Own: 70.64% | Sales past 5Y: -25.00% | Earnings: - |
+---------------------+----------------------+------------------------+-------------------+
| SMA200: -70.44% | Insider Own: 1.81% | Employees: 80 | |
+---------------------+----------------------+------------------------+-------------------+
| Perf Week: 25.03% | Insider Trans: 0.00% | Debt/Eq: 0.82 | |
+---------------------+----------------------+------------------------+-------------------+

The next section covers any insider trading by Adagio Medical officers or majority shareholders (if available).

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by Moran Timothy P. (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by MISHAN ORLY (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 300000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by Mirsaeedi-Farahani Keyvan (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by GARDINER SANDRA A. (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by Cox James L (Unknown Title) on 2025-03-20
- Non-qualified stock option (right to buy): 90000 shares at $0 (D)
- Non-qualified stock option (right to buy): 364000 shares at $0 (D)

Inside Trans: Adagio Medical Holdings, Inc. (ADGM) by PERCEPTIVE ADVISORS LLC (Unknown Title) on 2025-01-22
- Common Stock: 64167 shares at $N/A (D) Footnote: On January 22, 2025, the Reporting Persons were issued 64,167 shares of Common Stock of the Issuer at a price of $2.00 per share pursuant to the terms of the Convert Waiver, dated December 26, 2024, by and between the Issuer and the Reporting Persons in exchange for the waiver by the Reporting Persons of certain rights related to the Issuer's default under its Senior Secured Convertible Notes.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 602000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -64132199.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.3801
Average Volume: 322389.91
30-Day High: 1.3801
30-Day Low: 0.7407

[Detailed Financials: TTM 2024]
- Total Assets: $48,448,000.0
- Total Liabilities: $28,536,000.0
- Total Equity: $19,912,000.0
- Current Assets: $25,349,000.0
- Current Liabilities: $7,763,000.0

[Income Statement: TTM 2024]
- Revenue: $602,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2134210.72

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $-725,000

[Detailed Financials: FY 2024]
- Total Assets: $48,448,000.0
- Total Liabilities: $28,536,000.0
- Total Equity: $19,912,000.0
- Current Assets: $25,349,000.0
- Current Liabilities: $7,763,000.0

[Income Statement: FY 2024]
- Revenue: $602,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -2134210.72

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $-725,000
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Adagio Medical (ADGM).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Adagio Medical.

2) MARKET_SCORE[]
This conversation was initiated because ADGM is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for ADGM.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, ADGM could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect ADGM to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Adagio Medical.

11) ETHICAL_RATING[]
Rate Adagio Medical’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Adagio Medical.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

ADGM_IN_13 [2025-04-17 09:48:48 -0400] 126 Bytes | 29 tokens | Cum: 4087 tkns (51.09% of 8k)
==========================================================================

====================================
[2025-04-17 09:48:48] # Analysis Completed
Elapsed Time: 16.62 seconds